Effects of β-adrenoceptor agonists and antagonists on heart-rate variability in normal subjects assessed using summary statistics and nonlinear procedures

Journal of Cardiovascular Pharmacology

Volumn 30, Issue 6, 1997, Pages 817-823

  Silke, B ^a   Guy, S ^a   Riddell, J G ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Adrenoceptor; Agonist; Antagonist; Atenolol; Celiprolol; Heart rate variability; Linear; Nonlin ear; Propranolol

Indexed keywords

ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CELIPROLOL; PROPRANOLOL;

ADRENERGIC ACTIVITY; ADULT; ARTICLE; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; HEART RATE VARIABILITY; HOLTER MONITORING; HUMAN; HUMAN EXPERIMENT; LINEAR SYSTEM; MALE; NONLINEAR SYSTEM; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPATHETIC TONE; TACHYCARDIA;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; ANALYSIS OF VARIANCE; ATENOLOL; CELIPROLOL; DOUBLE-BLIND METHOD; HEART RATE; HUMANS; MALE; PROPRANOLOL;

EID: 0031415765     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199712000-00018     Document Type: Article

References (36)

1. Kleiger RE, Miller JP, Bigger JT, Moss AJ for the The Multicenter Post-Infarction Research Group. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256-62.
2. Bigger JT, Fleiss JL, Steinman R, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992; 85:164-71.
3. Spiers JP, Silke B, McDermott U, Shanks RG, Harron DWG. Time and frequency domain assessment of heart rate variability: a theoretical and clinical appreciation. Clin Autonom Res 1993;3:145-58.
4. Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981;304:801-7.
5. Beta-Blocker Heart Attack Research Group. A randomised trial of propranolol in patients with acute myocardial infarction. JAMA 1982;247:1707-14.
6. Strangeland L, Grong K, Vik-Mo H, Andersen KS, Lekven J. Is reduced cardiac performance the only mechanism for myocardial infarct size reduction during beta-adrenergic blockade? Cardiovasc Res 1986;20:322-30.
7. Pousset F, Copie X, LeChat P, et al. Effects of bisoprolol on heart-rate variability in heart failure. Am J Cardiol 1996;77(8):612-7.
8. Brouwer J, Viersma JW, Vanveldhuisen DJ, et al. Usefulness of heart-rate variability in predicting drug efficacy (metoprolol vs diltiazem) in patients with stable angina. Am J Cardiol 1995;76(11):759-63.
9. Cowan MJ, Pike K, Burr RL, Cain KC, Narayanan SB. Measures of heart-rate variability in individuals taking anti-arrhythmics, beta-blockers, calcium-channel blockers, and or anti-hypertensive drugs after sudden cardiac arrest. J Electrocardiol 1993;26:1-13.
10. Jartti T, Kaila T, Tahvanainen K, Kuusela T, Vanto T, Valimaki I. The acute effects of inhaled salbutamol on the beat-to-beat variability of heart rate and blood pressure assessed by spectral analysis. Br J Clin Pharmacol 1997;43:421-8.
11. Zuanetti G, Latini R, Neilson JMM, Schwartz PJ, Ewing DJ, for the Antiarrhythmic Drug Evaluation Group. Heart rate variability in patients with ventricular arrhythmias: effect of antiarrhythmic drugs. J Am Coll Cardiol 1991;17:604-12.
12. Coumel P, Maison-Blanche P, Catuli D. Heart rate and heart rate variability. In: Malik M, Camm AJ, eds. Heart rate variability. Armonk, NY: Futura, 1995:207-21.
13. Kligfield P, Stein KM, Herrold EM. Computer-assisted analysis of Holter recordings. In: Coumel P, Garfein OB, eds. Electrocardiography - past and future. Vol 601. New York: NY Academy of Sciences, 1990:353-69.
14. Ungi I, Thury A, Csanady M. Investigation of the correlation between heart rate and heart rate variability. Comput Cardiol IEEE 1995;0276-6547:189-91.
15. Tham TCK, Riddell JG, Shanks RG. The effect of increasing doses of celiprolol on sleeping heart rate and quality of sleep in man. Clin Pharmacol Ther 1991;49:187:PIII-54.
16. Wheeldon NM, McDevitt DG, Lipworth BJ. Selectivity of antagonist and partial agonist activity of celiprolol in normal subjects. Br J Clin Pharmacol 1992;34:337-43.
17. Lipworth BJ, Grove A. Partial beta-adrenoceptor agonists revisited. Br J Clin Pharmacol 1997;43:9-14.
18. Copie X, Leheuzey JY, Iliow MC, et al. Correlation between time-domain measures of heart rate variability and scatterplots in post-infarction patients. PACE Pacing Clin Electrophysiol 1996;19:342-7.
19. Raetz SL, Richard CA, Garfinkel A, Harper RM. Dynamic characteristics of cardiac R-R intervals during sleep and waking states. Sleep 1991;14:526-33.
20. 2-adrenoceptor blockade. Br J Clin Pharmacol 1989;28:95-102.
21. Lipworth BJ, Irvine NA, McDevitt DG. The effects of time and dose on the relative beta-1 and beta-2 adrenoceptor antagonism of betaxolol and atenolol. Br J Clin Pharmacol 1991;31:154-9.
22. McCaffrey PM, Riddell JG, Shanks RG. An assessment of the partial agonist activity of Ro 31,1118, flusoxolol and pindolol in man. Br J Clin Pharmacol 1987;24:571-80.
23. Oswald I. Sleep studies in clinical pharmacology. Br J Clin Pharmacol 1980;10:317-26.
24. Schechtman VL, Raetz SL, Harper RK, Garfinkel A, Wilson AJ, Southall DP. Dynamic analysis of cardiac R-R intervals in normal infants and in infants who subsequently succumbed to the sudden infant death syndrome. Pediatr Res 1992;31:606-12.
25. Hagerman I, Berglund M, Lorin M, Nowak J, Sylven C. Chaos-related deterministic regulation of heart rate variability in time- and frequency domains effects of autonomic blockade and exercise. Cardiovasc Res 1996;31:410-8.
26. Winer BJ. Statistical principles in experimental design. 2nd ed. New York: McGraw-Hill, 1971.
27. Altman DG, Gardner MJ. Calculating confidence intervals for regression and correlation. Br Med J 1988;296:1238-42.
28. Zar JH. Multiple regression and correlation. In: Biostatistical analysis. 2nd ed. Englewood Cliffs, NJ: Prentice-Hall, 1984:407-46.
29. Niemela MJ, Airaksinen J, Huikuri HV. Effect of beta-blockade on heart rate variability in patients with coronary artery disease. J Am Coll Cardiol 1994;23:1370-7.
30. Ewing DJ, Neilson JMM, Travis P. New method for assessing cardiac parasympathetic activity using 24 hour electrocardiograms. Br Heart J 1984;52:396-402.
31. Cook JR, Bigger JT, Kleiger RE, Fleiss JL, Steinman AB, Rolnitzky LM. Effect of atenolol and diltiazem on heart period variability in normal persons. J Am Coll Cardiol 1991;17:480-4.
32. Molgaard H, Mickley H, Pless P, Bjerregaard P, Moller M. Effects of metoprolol on heart rate variability in survivors of acute myocardiol infarction. Am J Cardiol 1993;71:1357-9.
33. Akselrod S, Gordon D, Ubel FA, Shannon DC, Barger DC, Cohen RJ. Power spectrum analysis of heart rate fluctuations: a quantitative probe of beat-to-beat cardiovascular control. Science 1981;213:220-2.
34. Taylor K, Silke B, Riddell JG. Effect of propranolol on heart-rate variability in normal volunteers using standard time-domain statistics and a new non-linear parameter. Br J Clin Pharmacol 1996;41:447P.
35. Wheeldon NM, McDevitt DG, Lipworth BJ. Evaluation of the selectivity of antagonist and partial agonist effects of celiprolol in normal subjects. Br J Clin Pharmacol 1992;33(5):528P.
36. 2-adrenoceptor blockade. Eur J Clin Pharmacol 1989;37:297-300.